Consequences of delayed treatment effects on analysis of time-to-event endpoints

被引:53
作者
Fine, Gil D. [1 ]
机构
[1] SuperGen Inc, Dublin, CA 94568 USA
来源
DRUG INFORMATION JOURNAL | 2007年 / 41卷 / 04期
关键词
survival analysis; log rank; weighted test; power; pancreatic cancer;
D O I
10.1177/009286150704100412
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The assumption of proportional hazard ratios is implicit in certain analyses of time-to-event endpoints such as Cox regression. Other statistical analyses, such as the nonparametric log-rank test, possess some desirable properties only under the proportional hazards model. Data models for delayed effects of treatment on time-to-event endpoints such as survival violate the proportional hazards assumption. Fleming and Harrington's G(rho,gamma) class of weighted log-rank tests, a new option in SAS 9.1, is appropriate to test against a broad range of alternative hypotheses, including delayed treatment effects. A model for delayed treatment effects is proposed, and it is demonstrated that weighted log-rank tests are more powerful under this model than the standard unweighted log-rank test.
引用
收藏
页码:535 / 539
页数:5
相关论文
共 6 条
[1]  
Cantor AB., 2003, SAS Survival Analysis Techniques for Medical Research
[2]  
Fleming TR., 2011, Counting processes and survival analysis. Wiley series in probability and statistics, DOI 10.1002/9781118150672
[3]  
HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.1093/biomet/69.3.553
[4]  
JACOBS AD, 2004, ANN M AM SOC CLIN ON
[5]   SAMPLE SIZES BASED ON THE LOG-RANK STATISTIC IN COMPLEX CLINICAL-TRIALS [J].
LAKATOS, E .
BIOMETRICS, 1988, 44 (01) :229-241
[6]  
SAS Institute, 2004, SAS/STAT 9.1 User's Guide